-
Pii to Manufacture FDA-Approved Hormone Therapy Injection Drug Product
contractpharma
September 24, 2019
Pharmaceutics International, Inc. (Pii), a contract development and manufacturing organization (CDMO) headquartered in Hunt Valley, MD, will manufacture commercial supply of Fulvestrant Injection 250mg/5ml drug product ...
-
FDA Approves Juvéderm Voluma XC For Mid-Face Injection Via Cannula
drugs
September 04, 2019
Allergan plc announced today it received U.S. Food and Drug Administration (FDA) approval for the use of Juvéderm Voluma XC...
-
Dual tailwinds for the injection export of Chinese pharmaceutical enterprises to the U.S.
PharmaSources/Xiaoyaowan
August 06, 2019
Pharmaceutical products produced in China with the same production line and approved for marketing in the EU, Japan, or the U.S. can be deemed as passing the consistency evaluation after the review and approval by the Consistency Evaluation Office.
-
FDA Approves Gadavist® Injection
americanpharmaceuticalreview
July 16, 2019
Bayer announced the U.S. Food and Drug Administration (FDA) has approved Gadavist® (gadobutrol) injection for use in cardiac magnetic resonance (MR) imaging to ...
-
Soliris (Eculizumab) Injection Approved to Treat Neuromyelitis Optica Spectrum Disorder
drugs
July 01, 2019
Soliris (Eculizumab) Injection Approved to Treat Neuromyelitis Optica Spectrum Disorder.
-
Type 2 diabetes treatment approved for children and adolescents
europeanpharmaceuticalreview
June 20, 2019
The FDA has approved an injection for use in patients aged 10-17 to treat type 2 diabetes.
-
FDA Approves Victoza Injection for Children 10 Years and Older with Type 2 Diabetes
drugs
June 19, 2019
FDA Approves Victoza Injection for Children 10 Years and Older with Type 2 Diabetes.
-
Enable Injections Enters into Partnership with Sanofi
contractpharma
June 12, 2019
Enable's enFuse delivers high-volume therapeutics outside of the clinical setting.
-
No Subfascial, Intramuscular Injection Recommended in Gluteal Fat Grafting
drugs
May 31, 2019
No Subfascial, Intramuscular Injection Recommended in Gluteal Fat Grafting.
-
Heritage Pharmaceuticals Issues Recall of Amikacin Sulfate Injection, Prochlorperazine Edisylate Injection
americanpharmaceuticalreview
May 30, 2019
Heritage Pharmaceuticals is initiating a voluntary recall of Amikacin Sulfate Injection, USP, 1g/4 mL (250mg/mL), Lot: VEAC025, Expiry Date: October 2019 and Prochlorperazine Edisylate Injection, USP, 10mg/2mL (5mg/mL) ...